Comparative Bioavailability of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) Vs. Minocycline Hydrochloride Extended Release 105-mg tablets After a Single Oral Dose: A Randomized, 3-way Crossover Study. (2023). SKIN The Journal of Cutaneous Medicine, 7(6), s289. https://doi.org/10.25251/skin.7.supp.289